NCT06057376

Brief Summary

In this project we want to assess impact of dietary fructose as a simple sugar intolerance on abdominal pain and compare a low FODMAP diet versus an added sugar elimination diet effectiveness on symptoms but also impact on microbiome and its metabolome.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 15, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 28, 2023

Completed
28 days until next milestone

Study Start

First participant enrolled

October 26, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

April 2, 2024

Status Verified

April 1, 2024

Enrollment Period

2.3 years

First QC Date

September 15, 2023

Last Update Submit

April 1, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Abdominal Pain

    Diet impact on abdominal pain as assessed by a questionnaire before and after each diet intervention

    63 days

  • Effect of each diet on microbiome and metabolome

    Impact of each diet intervention on microbiome and metabolome will be assessed utilizing a stool sample collected prior to and after diet completion

    63 days

Study Arms (2)

Low FODMAP group

OTHER

Participants randomized to this group will be instructed based on published low-FODMAP diet guidelines and provided with sample meal plans to aid in compliance. Each participant will be randomized to low-FODMAP diet group (LFD) for 3 weeks.

Other: Low-FODMAP diet group (LFD)

Low Added Sugar group

OTHER

Each participant will be randomized to either the low-FODMAP diet group (LFD) or the low added sugar diet group (LAS) for 3 weeks. Each participant will be randomized to the low added sugar diet group (LAS) for 3 weeks.

Other: Low Sugar diet group (LAS)

Interventions

Each participant will be following a low-FODMAP diet group for 3 weeks, followed by 3 week break prior to second diet intervention.

Low FODMAP group

Each participant will be following a low added sugar diet group for 3 weeks, after 3 week break.

Low Added Sugar group

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age: 5- 18-year-old
  • BMI: within normal range for age
  • Positive fructose breath test performed as part of diagnostic work up for abdominal pain
  • Willingness to consume low FODMAP and Limited Added sugar diet trial and collect required samples

You may not qualify if:

  • Age: not within range
  • BMI: not within range
  • Negative fructose breath test
  • Any known or suspected intestinal disorder including but not limited to IBD, IBS, celiac disease, Crohn's Disease, food sensitivities, food allergies, significant by-choice food restrictions
  • Hormonal disorders
  • Use of chronic medications including contraceptives (both oral and subcutaneous), non-hormone secreting IUD- accepted
  • Use of oral or IV antibiotics in the last three months
  • Daily probiotic use (pill form)
  • Daily multi-vitamin except vitamin D supplements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health and Science University

Springfield, Oregon, 97477, United States

RECRUITING

MeSH Terms

Conditions

Glucose-Galactose Malabsorption

Interventions

lipoic acid synthase

Study Officials

  • Anna Hunter, MD

    Oregon Health and Science University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anna Hunter, MD

CONTACT

Deepannita Roy, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

September 15, 2023

First Posted

September 28, 2023

Study Start

October 26, 2023

Primary Completion

February 1, 2026

Study Completion

February 1, 2026

Last Updated

April 2, 2024

Record last verified: 2024-04

Locations